Jefferson Einstein Infectious Diseases Fellowship
einsteinphillyid.bsky.social
Jefferson Einstein Infectious Diseases Fellowship
@einsteinphillyid.bsky.social
journals.asm.org/doi/10.1128/...

This paper breaks down the risk profile of different biologics for reactivation. As usual, TNF inhibitors are at the top of risk. B cell agents carry a minimal to non significant increase in risk Remember Hep B though!
September 12, 2025 at 3:13 PM
Recruitment has started! Case conference today was fantastic as always. A few snippets:

1) Patient in the ICU who develops nosocomial PNA/VAP with areas of necrosis. Can you use a gram stain to guide empiric antibiotics? Why, glad you asked! Enter GRACE-VAP study
September 12, 2025 at 2:23 PM
Looks like the team has been busy stamping out disease! Come join us next July! Find out why our division is the most nominated for teaching awards by our trainees
August 7, 2025 at 2:09 PM
Come train with us at Jefferson Einstein Philadelphia! Engage with seasoned faculty in a collegiate and stimulating environment based in the greatest city in the US
July 29, 2025 at 6:40 PM
July 29, 2025 at 6:38 PM